| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/05/2010 | CN101700236A Vitamin c soft capsule |
| 05/05/2010 | CN101700225A Fat emulsion injection and production method thereof |
| 05/05/2010 | CN101700221A Process for preparing targeting fat-reducing calcium-supplying oral liquid enriched with lecithin-calcium acetate coupled material by lipidosome biotechnology |
| 05/05/2010 | CN101080392B Piperazinyl pyridine derivatives as anti-obesity agents |
| 05/05/2010 | CN101048382B New indole or benzimidazole derivatives |
| 05/05/2010 | CN101022817B Therapeutic or preventive agent for diabetic neuropathy |
| 05/04/2010 | USRE41315 Modulators of dopamine neurotransmission |
| 05/04/2010 | US7709664 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 05/04/2010 | US7709539 has been shown to have free radical scavenging, anti-inflammatory and anti-thrombogenic activities in biological systems; resveratrol has also been shown to be a good cancer preventive chemical and has been recommended as a food supplement for health benefits; can effectively lower blood sugar |
| 05/04/2010 | US7709537 Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials |
| 05/04/2010 | US7709515 Therapy for cardiovascular disorders; dyslipidemia; glucose metabolism disorders; Alzheimer's disease |
| 05/04/2010 | US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis |
| 05/04/2010 | US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents |
| 05/04/2010 | US7709505 2-methyl-4-isobutoxy-6-[N-(5-carboxypyridin-2-yl)carbamoyl]benzofuran; 2-methyl-4-isobutoxy-6-[N-(5-carboxypyridin-2-yl)carbamoyl]benzofuran; type 2 diabetes |
| 05/04/2010 | US7709500 Chemical compounds |
| 05/04/2010 | US7709489 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2-a]quinoline-2-carbonyl)-4-methylpiperazine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives |
| 05/04/2010 | US7709481 peroxisome proliferator activator receptor (PPARdelta) agonist; type-2 diabetes, atherosclerosis, cardiovascular disorders; 3-{2-Chloro-4-[4-methyl-2-(1-methyl-cyclohexyl)-oxazol-5-ylmethoxy]-phenyl}-4H-[1,2,4]oxadiazol-5-one |
| 05/04/2010 | US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
| 05/04/2010 | US7709470 retinopathy, nephropathy, neuropathy, and hyperlipidemia, obesity, dyslipidemia, and osteoporosis; Retinoid X receptors (RXRs); 4-(2-Cyano-5,7,7,10,10-pentamethyl-7,8,9,10-tetrahydro-5H-5,13-diaza-benzo[4,5]-cyclohepta[1,2-b]naphthalen-12-yl)-2-fluoro-benzoic Acid |
| 05/04/2010 | US7709466 Pyridazinone derivatives, methods for their production and their use as pharmaceuticals |
| 05/04/2010 | US7709460 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality |
| 05/04/2010 | US7709459 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 05/04/2010 | US7709445 Colloidal suspension of nanoparticles based on an amphiphilic copolymer |
| 05/04/2010 | US7709255 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells |
| 05/04/2010 | US7709214 Using antibody specific blocking agents to treat and prevent infection, cell proliferative and immunosuppressive disorders |
| 05/04/2010 | US7709028 Particulate product comprising pantethine |
| 05/04/2010 | US7709020 Implantable device comprising phosphorus-containing macrolides |
| 05/04/2010 | CA2462456C Androstane 17-beta-carboxamides as androgen receptor modulators |
| 05/04/2010 | CA2455566C (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 05/04/2010 | CA2453609C Bridged piperidine derivatives as melanocortin receptor agonists |
| 05/04/2010 | CA2437767C Heterocyclic inhibitors of erk2 and uses thereof |
| 05/04/2010 | CA2427385C Nutritional composition for an immune condition |
| 05/04/2010 | CA2412880C Glutamine fructose-6-phosphate amidotransferase splice variant and its expression product |
| 05/04/2010 | CA2388243C Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials |
| 05/04/2010 | CA2172398C Methods and products for controlling immune responses in mammals |
| 04/29/2010 | WO2010048358A2 Ethoxyphenylmethyl inhibitors of sglt2 |
| 04/29/2010 | WO2010048207A2 Aryl gpr120 receptor agonists and uses thereof |
| 04/29/2010 | WO2010047956A1 Azolopyrrolone melanin concentrating hormone receptor-1 antagonists |
| 04/29/2010 | WO2010047669A1 "cholvacor" - a medication in the form of liquid used for regulation of lipid exchange |
| 04/29/2010 | WO2010047361A1 Pharmaceutical composition improved in absorption through intestinal tract |
| 04/29/2010 | WO2010047302A1 Combination nutritional infusion |
| 04/29/2010 | WO2010047127A1 PHENANTHROINDOLIZIDINE COMPOUND AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT |
| 04/29/2010 | WO2010047126A1 PHENANTHROINDOLIZIDINE DERIVATIVE AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT |
| 04/29/2010 | WO2010046910A1 Pharmaceutical compositions for the treatment of diabetes mellitus |
| 04/29/2010 | WO2010046835A1 Crystalline forms of (r) -5- [3-chloro-4- ( 2, 3-dihydroxy-propoxy) -benz [z] ylidene] -2- ( [z] -propylimino) -3-0-tolyl-thiazolidin-4-one |
| 04/29/2010 | WO2010046492A1 Biscuit comprising guar gum |
| 04/29/2010 | WO2010046445A2 Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use |
| 04/29/2010 | WO2010045755A1 Glycosyl-derivatives of puerarin, pharmaceutical compositon, preparation method and use thereof |
| 04/29/2010 | WO2010011597A3 Treatment of obesity and related disorders |
| 04/29/2010 | WO2010006129A3 2-methylene-(22e)-25-(1-methylene-hexyl)-26,27-cyclo-22-dehydro-19-nor-vitamin d analogs |
| 04/29/2010 | US20100105953 Human Adam-10 Inhibitors |
| 04/29/2010 | US20100105915 Chemokine receptor binding heterocyclic compounds |
| 04/29/2010 | US20100105896 Pharmaceutical compounds |
| 04/29/2010 | US20100105781 Abuse resistant lysine amphetamine compounds |
| 04/29/2010 | US20100105779 Methods of treating fibromyalgia syndrome, chronic fatigue syndrome and pain |
| 04/29/2010 | US20100105757 Treatment and inhibition of disease conditions using flexible heteroarotinoids |
| 04/29/2010 | US20100105751 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 04/29/2010 | US20100105746 Method for treating metabolic diseases |
| 04/29/2010 | US20100105732 Piperidine gpcr agonists |
| 04/29/2010 | US20100105727 Novel benzamide derivatives and process for the prepartion thereof |
| 04/29/2010 | US20100105719 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors |
| 04/29/2010 | US20100105716 Camkk(beta) as a target for treating obesity |
| 04/29/2010 | US20100105709 6-Butyl-2-methoxy-5-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-3-phenylpyrimidin-4(3H)-one; for hypertension, cardiac disease, arteriosclerosis, kidney disease, stroke, dyslipidemia, obesity, diabetes, nonalcoholic steatohepatitis, dementia and/or Alzheimer's disease in a mammal |
| 04/29/2010 | US20100105708 Pyrrolopyrimidines for pharmaceutical compositions |
| 04/29/2010 | US20100105695 Method for enhancing insulin secretion |
| 04/29/2010 | US20100105689 Novel 1,4- and 1,5-diarylsubstituted 1,2,3-triazoles useful as potassium channel modulators |
| 04/29/2010 | US20100105682 Cyclopropyl-piperazine compounds as calcium channel blockers |
| 04/29/2010 | US20100105679 5-pyridinone substituted indazoles |
| 04/29/2010 | US20100105675 11 beta-hsd1 modulators |
| 04/29/2010 | US20100105659 2-aminopyridine analogs as glucokinase activators |
| 04/29/2010 | US20100105654 Substituted quinazolinone compounds |
| 04/29/2010 | US20100105630 Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders |
| 04/29/2010 | US20100105608 Peptides and methods using same for diagnosis and treatment of amyloid-associated disease |
| 04/29/2010 | US20100105605 Fatty acid formulations and oral delivery of proteins and peptides, and uses thereof |
| 04/29/2010 | US20100105603 Methods and Preparations For Curing Clinically Ill Patients |
| 04/29/2010 | US20100104657 Pharmaceutical composition comprising a reduced concentration of cholesterol |
| 04/29/2010 | US20100104651 Pharmaceutical Compositions Containing Diacerein |
| 04/29/2010 | US20100104636 Pharmaceutical Compound and Composition |
| 04/29/2010 | US20100104602 Neurotoxin therapy for postprandial hyperglycemia |
| 04/29/2010 | US20100104584 Genes involved in mitochondrial biogenesis |
| 04/29/2010 | US20100104569 Humanized antibodies to interferon alpha receptor-1 (ifnar-1) |
| 04/29/2010 | US20100104564 Altered Antibody Fc Regions and Uses Thereof |
| 04/29/2010 | US20100104563 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
| 04/29/2010 | US20100104548 Modulation of amino acid metabolism in the hypothalamus |
| 04/29/2010 | US20100104543 Cellular compositions and methods of making and using them |
| 04/29/2010 | DE102008053048A1 Medicament, useful e.g. for treating diabetes, controlling fasting, postprandial or postabsorptive blood glucose concentration in diabetic patients and improving glucose tolerance, comprises insulin and glucagon-like peptide-1 agonist |
| 04/29/2010 | CA2741107A1 Biscuit comprising guar gum |
| 04/29/2010 | CA2740810A1 Phenanthroindolizidine compound and nf.kappa.b inhibitor containing same as active ingredient |
| 04/29/2010 | CA2740807A1 Phenanthroindolizidine derivative and nf.kappa.b inhibitor containing same as active ingredient |
| 04/29/2010 | CA2740366A1 Aryl gpr120 receptor agonists and uses thereof |
| 04/29/2010 | CA2740313A1 Crystalline forms of (r) -5- [3-chloro-4- ( 2, 3-dihydroxy-propoxy) -benz [z] ylidene] -2- ( [z] -propylimino) -3-0-tolyl-thiazolidin-4-one |
| 04/29/2010 | CA2739882A1 Pharmaceutical composition improving intestinal absorption |
| 04/29/2010 | CA2738453A1 Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use |
| 04/28/2010 | EP2179999A1 Fused tricyclic compound having aldose reductase inhibitory activity |
| 04/28/2010 | EP2179982A2 Method for producing mechanically activated amorphous and amorphocrystalline compounds of gluconic acid calcium salt |
| 04/28/2010 | EP2179732A1 Pharmaceutical composition combining an enzyme hmg-coa reductase inhibiting agent and a gastrointestinal lipase enzyme inhibiting agent |
| 04/28/2010 | EP2179731A1 Amino-acid-containing medicinal granular preparation highly easy to take |
| 04/28/2010 | EP2179730A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 04/28/2010 | EP2179726A2 Dietary fiber inulin delivery system |
| 04/28/2010 | EP2179661A1 Biscuit comprising guar gum in a rod-like form |